Physician profile
Oscar Martinez
NPI 1326364381
$3,789.42
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $773 · 2020: $683 · 2021: $1,101 · 2022: $808 · 2023: $423.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $423.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $423.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,241.49 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $825.67 | 2019-2023 | Farxiga |
| Lilly USA, LLC | $774.60 | 2019-2023 | Mounjaro, Jardiance, Emgality |
| Insulet Corporation | $146.17 | 2023 | Omnipod |
| Abbvie INC. | $140.26 | 2021-2022 | |
| Vivus LLC | $124.97 | 2023 | Qsymia |
| Medtronic, INC. | $109.55 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $100.21 | 2020-2021 | |
| Biohaven Pharmaceuticals, INC. | $52.74 | 2021 | |
| Janssen Pharmaceuticals, INC | $40.37 | 2019 | |
| Glaxosmithkline, LLC. | $31.56 | 2022 | |
| Pfizer INC. | $28.83 | 2019 | |
| Allergan, INC. | $27.64 | 2020 | |
| Abbott Laboratories | $26.79 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $21.69 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $20.50 | 2020 | |
| Ascensia Diabetes Care US INC. | $19.90 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $17.46 | 2019 | |
| Aytu Biopharma, INC. | $14.84 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $12.78 | 2019 | |
| Astellas Pharma US INC | $11.40 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Oscar Martinez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.